NeurOp, Inc. is a clinical-stage biotechnology company developing new medicines for central nervous system disorders, including stroke, severe pain, subarachnoid hemorrhage (SAH), and treatment-resistant depression. Its technology targets the GluN2B subunit of neuronal NMDA receptors and its potential therapeutic benefit.
Multi-year funding from the NIH supports NeurOp's research and development programs for NP10679, its drug candidate for the prevention of ischemic damage during a stroke or subarachnoid hemorrhage (SAH) and severe pain. For more information, please visit www.neuropinc.com.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 58 Edgewood Avenue, Ne, Suite 122,niger
- Phone
- 404-941-2350
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.neuropinc.com
- Keywords
- Neuroscience drug discovery, Ischemia, Stroke, NMDA receptor research, Severe pain, Subarachnoid hemorrhage (SAH), Catastrophic juvenile epilepsies.
- HQ
- Atlanta, Georgia
Neurop, Inc. Questions
Neurop, Inc.'s helpline number is 404-941-2350
Neurop, Inc.'s website is http://www.neuropinc.com
Neurop, Inc.'s LinkedIn profile is https://www.linkedin.com/company/neurop-inc-
Neurop, Inc. has
6 employees.
View email and phone details for 6
employees at Neurop, Inc..
Neurop, Inc.'s industry is
Biotechnology Research
Neurop, Inc.'s top competitors are
Jeevan Biosciences, Inc,
Mimedx,
Omega Bio-Tek,
Lena Biosciences,
Arbor Pharmaceuticals,
Raybiotech,
Caprico Biotechnologies, Inc.,
Geovax Labs, Inc.,
Axion Biosystems,
Akesogen, Inc..
Neurop, Inc.'s categories are Biotechnology Research
Neurop, Inc.'s founding year is 2001
